title: Histomorphometric effect of six month treatment with oral Risedronate in patients with multiple myeloma.
authors.affiliation: Inserm U349, Centre Viggo Petersen, Lariboisiere Hospital, Paris, France.
authors.forename: M E
authors.initials: ME
authors.lastname: Cohen-Solal
authors.forename: C
authors.initials: C
authors.lastname: Roux
authors.forename: A
authors.initials: A
authors.lastname: Valentin-Opran
authors.forename: M
authors.initials: M
authors.lastname: Dougados
authors.forename: B
authors.initials: B
authors.lastname: Amor
authors.forename: M C
authors.initials: MC
authors.lastname: De Vernejoul
mesh_terms: D000284:Administration, Oral; D000368:Aged; D001862:Bone Resorption / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D012968:Etidronic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000150:complications* / Q000473:pathology; D000068296:Risedronic Acid; D013997:Time Factors
chemical_list: D000068296:Risedronic Acid; D012968:Etidronic Acid